208 related articles for article (PubMed ID: 36165136)
21. CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes.
Tossidou I; Teng B; Drobot L; Meyer-Schwesinger C; Worthmann K; Haller H; Schiffer M
J Biol Chem; 2010 Aug; 285(33):25285-95. PubMed ID: 20457601
[TBL] [Abstract][Full Text] [Related]
22. FK506 reduces albuminuria through improving podocyte nephrin and podocin expression in diabetic rats.
Qi XM; Wang J; Xu XX; Li YY; Wu YG
Inflamm Res; 2016 Feb; 65(2):103-14. PubMed ID: 26566632
[TBL] [Abstract][Full Text] [Related]
23. [Differential expressions of miRNAs in kidney in puromycin aminonucleoside nephropathy model and intervened effects of Leizhi capsule].
Sun W; Li CQ; Chen JH; Shao JD; Zhou D; Zhang L; Gao K
Zhongguo Zhong Yao Za Zhi; 2013 Jan; 38(1):81-90. PubMed ID: 23596882
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
25. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
[TBL] [Abstract][Full Text] [Related]
26. Nephrin Preserves Podocyte Viability and Glomerular Structure and Function in Adult Kidneys.
Li X; Chuang PY; D'Agati VD; Dai Y; Yacoub R; Fu J; Xu J; Taku O; Premsrirut PK; Holzman LB; He JC
J Am Soc Nephrol; 2015 Oct; 26(10):2361-77. PubMed ID: 25644109
[TBL] [Abstract][Full Text] [Related]
27. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
[TBL] [Abstract][Full Text] [Related]
28. Preservations of nephrin and synaptopodin by recombinant hepatocyte growth factor in podocytes for the attenuations of foot process injury and albuminuria in nephritic mice.
Kato T; Mizuno S; Nakamura T
Nephrology (Carlton); 2011 Mar; 16(3):310-8. PubMed ID: 21342325
[TBL] [Abstract][Full Text] [Related]
29. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
[TBL] [Abstract][Full Text] [Related]
30. Flot2 acts as a novel mediator of podocyte injury in proteinuric kidney disease.
Yu C; Zhang H; Liu S; Li R; Zhao X; Chen Y; Li Z; Ma J; Wang W; Ye Z; Liang X; Zhang L; Shi W
Int J Biol Sci; 2023; 19(2):502-520. PubMed ID: 36632460
[TBL] [Abstract][Full Text] [Related]
31. Nephrin-Binding Ephrin-B1 at the Slit Diaphragm Controls Podocyte Function through the JNK Pathway.
Fukusumi Y; Zhang Y; Yamagishi R; Oda K; Watanabe T; Matsui K; Kawachi H
J Am Soc Nephrol; 2018 May; 29(5):1462-1474. PubMed ID: 29602834
[No Abstract] [Full Text] [Related]
32. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
[TBL] [Abstract][Full Text] [Related]
33. Podocyte Injury and Albuminuria in Experimental Hyperuricemic Model Rats.
Asakawa S; Shibata S; Morimoto C; Shiraishi T; Nakamura T; Tamura Y; Kumagai T; Hosoyamada M; Uchida S
Oxid Med Cell Longev; 2017; 2017():3759153. PubMed ID: 28337250
[TBL] [Abstract][Full Text] [Related]
34. TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway.
Chang J; Zheng J; Gao X; Dong H; Yu H; Huang M; Sun Z; Feng X
Front Endocrinol (Lausanne); 2022; 13():888611. PubMed ID: 35721758
[TBL] [Abstract][Full Text] [Related]
35. Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo.
Chen T; Zheng LY; Xiao W; Gui D; Wang X; Wang N
Cell Physiol Biochem; 2015; 35(4):1425-36. PubMed ID: 25791065
[TBL] [Abstract][Full Text] [Related]
36. Role of podocyte slit diaphragm as a filtration barrier.
Kawachi H; Miyauchi N; Suzuki K; Han GD; Orikasa M; Shimizu F
Nephrology (Carlton); 2006 Aug; 11(4):274-81. PubMed ID: 16889564
[TBL] [Abstract][Full Text] [Related]
37. CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes.
Teng B; Schroder P; Müller-Deile J; Schenk H; Staggs L; Tossidou I; Dikic I; Haller H; Schiffer M
Diabetes; 2016 Dec; 65(12):3667-3679. PubMed ID: 27531950
[TBL] [Abstract][Full Text] [Related]
38. [Changes of podocyte ultrastructure and expression of podocyte-associated molecules in rats with diabetic nephropathy].
Chen LP; Zhou QL; Peng WS; Wu XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):620-5. PubMed ID: 17767053
[TBL] [Abstract][Full Text] [Related]
39. Expression of podocyte-associated molecules in acquired human kidney diseases.
Koop K; Eikmans M; Baelde HJ; Kawachi H; De Heer E; Paul LC; Bruijn JA
J Am Soc Nephrol; 2003 Aug; 14(8):2063-71. PubMed ID: 12874460
[TBL] [Abstract][Full Text] [Related]
40. The reno-protective effect of a phosphoinositide 3-kinase inhibitor wortmannin on streptozotocin-induced proteinuric renal disease rats.
Kim SH; Jang YW; Hwang P; Kim HJ; Han GY; Kim CW
Exp Mol Med; 2012 Jan; 44(1):45-51. PubMed ID: 22056625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
